new_0222_0234|KROS|0|ps_ratio|price_to_book_value|peg_ratio|price|short_interest|dividend_yield|earning_yield|market_cap|pe_ratio|consensus_recommendation|price_target_num_est|price_target|sales_est_1y|sales_est_0y|eps_est_1y|eps_est_0y|ebitda_est_0y|ebitda_est_1y|revenues|ebitda|net_income|price_next_month|price_second_month
new_0222_0234|KROS|1|Keros Therapeutics Inc PS Ratio|Keros Therapeutics Inc Price to Book Value|Keros Therapeutics Inc PEG Ratio|Keros Therapeutics Inc Price (USD)|Keros Therapeutics Inc Short Interest|Keros Therapeutics Inc Dividend Yield|Keros Therapeutics Inc Earnings Yield|Keros Therapeutics Inc Market Cap (USD)|Keros Therapeutics Inc PE Ratio|Keros Therapeutics Inc Consensus Recommendation|Keros Therapeutics Inc Price Target Num Estimates|Keros Therapeutics Inc Price Target (USD)|Keros Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Keros Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Keros Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Keros Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Keros Therapeutics Inc EBITDA Estimates for Current Fiscal Year (USD)|Keros Therapeutics Inc EBITDA Estimates for Next Fiscal Year (USD)|Keros Therapeutics Inc Revenue (Quarterly) (USD)|Keros Therapeutics Inc EBITDA (Quarterly) (USD)|Keros Therapeutics Inc Net Income (Quarterly) (USD)||
new_0222_0234|KROS|2|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_price|figure_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_whole_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0234|KROS|4|quarterly|daily|daily|daily|monthly|daily|daily|daily|quarterly|monthly|monthly|monthly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0234|KROS|5||1.44444444444|1.44755244755|1.44585987261|15.2558139535|1.44585987261|1.44585987261|1.44585987261||18.1666666667|36.4375|36.4375|54.5|40.875|29.7272727273|27.25|||91.3333333333|91.4|91.4||
new_0222_0234|KROS|6||414|286|471|43|471|471|471||36|16|16|12|16|22|24|||9|10|10||
new_0222_0234|KROS|7|daily|daily|daily|market_daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly||
new_0222_0234|KROS|20190315|||||||||||||||||||2.5|-2.813|-3.183||
new_0222_0234|KROS|20190615|||||||||||||||||||2.5|-2.602|-2.853||
new_0222_0234|KROS|20190915|||||||||||||||||||2.5|-3.491|-3.549||
new_0222_0234|KROS|20191215|||||||||||||||||||2.5|-2.691|-2.751||
new_0222_0234|KROS|20200315||||||||||||||||||||-11.999|-11.892||
new_0222_0234|KROS|20200415||||20.08|56739||-8.4471|385.3232||||||||||||||21.57|29.55
new_0222_0234|KROS|20200515||||28.8|480274||-5.8895|578.5747||2|1|35|0.25|0.25|-1.19|-1.13||||||29.02|28.74
new_0222_0234|KROS|20200615||5.3489||29.5|811117||-5.7498|594.3866||1.5||||||||||-10.688|-10.757|31.98|37.51
new_0222_0234|KROS|20200715||5.1992||36.46|720397||-5.3327|734.9643||1.5|4|43.5|0.25|0.1875||||||||35.8|32.1
new_0222_0234|KROS|20200815||4.6245||32.43|1294145||-5.9954|653.7272||1.5|4|44.75|0.25|0.125|-3.6075|-3.31||||||32.5|53.54
new_0222_0234|KROS|20200915||7.6246||53.43|878262||-3.639|1077.8167||1.5|4|47.25||||||||-11.962|-12.036|55.95|38.57
new_0222_0234|KROS|20201015||5.806||37.61|648322||-5.5679|759.1842||||||||||||||36.76|55.6
new_0222_0234|KROS|20201115||7.9966||51.8|629626||-4.0426|1045.6193||1.5|4|54.25|||-2.9925|-4.1375||||||53.165|75.61
new_0222_0234|KROS|20201215||13.8087|-0.4118|77.9|463669||-2.6882|1805.5974||1.5|4|86.25|||-2.545|-4.145||||-10.6|-10.676|74.02|70.54
new_0222_0234|KROS|20210115||6.166|-0.4062|69.58|632285||-3.4609|1613.762||||||||||||||68.8|57.05
new_0222_0234|KROS|20210215||5.099|-0.3359|57.54|690868||-4.1851|1334.5195||||||||||||||58.82|65.47
new_0222_0234|KROS|20210315||5.4677|-0.3602|61.7|702750||-3.9029|1431.0019||1.5|4|86.25|||-3.6425|-2.52||||-15.754|-15.885|57.55|61.55
new_0222_0234|KROS|20210415||5.5056|-0.601|58.76|1039463||-4.0674|1367.4333||||||||||||||60.4|58.8
new_0222_0234|KROS|20210515||5.3193|-0.5801|56.71|1081563||-4.2144|1321.1672||1.5|||||-3.7875|-3.21||||||54.44|54.56
new_0222_0234|KROS|20210615||4.8287|-0.5266|51.48|838866||-4.6426|1199.3244||1.5|4|87.5|||-3.8425|-2.845|||0.1|-15.53|-15.622|48.54|42.47
new_0222_0234|KROS|20210715||4.0806|-0.6626|41.22|931512||-5.9195|961.6131||||||||||||||40.99|36.8
new_0222_0234|KROS|20210815||3.5692|-0.5794|36.04|995879||-6.7703|841.0979||1.5|4|86.25||0.1|-3.8775|-2.9225||||||34.78|33.64
new_0222_0234|KROS|20210915||3.3444|-0.5429|33.77|855034||-7.2253|788.1209||||||||||||-20.231|-20.297|33.67|39.56
new_0222_0234|KROS|20211015||4.274|-0.6416|39.91|1001144||-6.7903|933.7663||1.5||||||-2.89||||||39.34|41.72
new_0222_0234|KROS|20211115||4.586|-0.6884|42.82|788163||-6.3288|1001.9323||1.5|4|86.25|||-4|-3.105||||||42.37|55.79
new_0222_0234|KROS|20211215||5.6816|-0.8528|53.05|926272||-5.1084|1241.301||1.5|4|86.25||0.1|-4.0975|-3.1133||||||54.24|58.51
new_0222_0234|KROS|20220115||6.3574|-0.9542|59.36|806454||-4.5654|1388.9468||||||||||||||58.68|46.37
new_0222_0234|KROS|20220215||5.2842|-0.7932|49.34|||-5.4925|1154.4919||1.5|||||-4.96|-4.155||||||46.81|52.09